AN2 Therapeutics
Earnings Surprise
Analysts estimated ANTX earnings of $-0.24 per share this quarter (Q4). ANTX's actual earnings were $-0.29 per share.
ANTX EPS surprise of -18.46%Analysts estimated ANTX earnings of $-0.22 per share this quarter (Q3). ANTX's actual earnings were $-0.31 per share.
ANTX EPS surprise of -38.15%Analysts estimated ANTX earnings of $-0.34 per share this quarter (Q2). ANTX's actual earnings were $-0.21 per share.
ANTX EPS surprise of 38.18%Analysts estimated ANTX earnings of $-0.26 per share this quarter (Q1). ANTX's actual earnings were $-0.35 per share.
ANTX EPS surprise of -32.13%Analysts estimated ANTX earnings of $-0.39 per share this quarter (Q3). ANTX's actual earnings were $-0.35 per share.
ANTX EPS surprise of 10.87%Analysts estimated ANTX earnings of $-0.61 per share this quarter (Q2). ANTX's actual earnings were $-0.48 per share.
ANTX EPS surprise of 20.67%Analysts estimated ANTX earnings of $-0.63 per share this quarter (Q1). ANTX's actual earnings were $-0.56 per share.
ANTX EPS surprise of 11.56%Analysts estimated ANTX earnings of $-0.76 per share this quarter (Q4). ANTX's actual earnings were $-0.57 per share.
ANTX EPS surprise of 33.46%Analysts estimated ANTX earnings of $-0.64 per share this quarter (Q3). ANTX's actual earnings were $-0.65 per share.
ANTX EPS surprise of 1.69%